Table 1.
Baseline characteristics of the participants by allocated group and total. Data are presented as numbers (N) unless otherwise stated
| Characteristic | Intervention group (N = 10) | Control group (N = 10) | Total |
|---|---|---|---|
| Women | 6 | 6 | 12 (60 %) |
| Age (years); M(SD) | 64.5 (8.5) | 54.0 (14.0) | 59.3 (12.5) |
| Cohabiting | 2 | 6 | 8 (42 %) |
| Highest attained education | |||
| Primary school | 5 | 2 | 7 (35 %) |
| High school | 0 | 3 | 3 (15 %) |
| Short to middle higher education | 4 | 5 | 9 (45 %) |
| Long higher education (university) | 1 | 0 | 1 (5 %) |
| Occupation | |||
| Unemployed | 1 | 0 | 1 (5 %) |
| Employed full time | 1 | 1 | 2 (10 %) |
| Employed part time | 1 | 1 | 2 (10 %) |
| Disease-related retirement | 1 | 3 | 4 (20 %) |
| Age-related retirement | 6 | 5 | 11 (55 %) |
| Smoking | 3 | 2 | 5 (25 %) |
| Drinks of alcohol per week; median (Q1,Q3) | 2.0 (2.0,5.0) | 2.0 (1.0,6.0) | 2.0 (0.0,6.0) |
| RA duration (years); median (Q1,Q3) | 10.0 (8,2) | 4.0 (2.0,8.0) | 8.0 (4.0,15.0) |
| Medical treatment (biologics) | 6 | 6 | 12 (60 %) |
| DAS-28; M(SD) | 3.4 (1.6) | 2.8 (1.0) | 3.1 (1.3) |
| CRP; median (Q1,Q3) | 7.0 (5.0,16.0) | 5.0 (5.5,9.0) | 6.5 (5.0,12.5) |
| Comorbidity | 8 | 9 | 17 (85 %) |
| Daily sitting time Hours/day; M(SD) | 10.7 (1.9) | 9.5 (1.5) | 10.1 (1.8) |
| Breaks in sitting time N/day; M(SD) | 50.0 (18.0) | 48.0 (5.0) | 49.0 (13.0) |
| Self-reported leisure sitting, Hours/day; M(SD) | 4.0 (1.6) | 5.6 (1.9) | 4.8 (1.9) |
| Physical function; median (Q1,Q3)b | 0.6 (0.4,1.0) | 0.6 (0.4,1.1) | 0.6 (0.4–1.1) |
| Fatigue; M(SD)c | |||
| General fatigue | 11.3 (3.5) | 13.5 (2.7) | 12.4 (3.3) |
| Physical fatigue | 11.7 (2.9) | 12.3 (2.7) | 12.0 (2.7) |
| Reduced activity | 11.2 (2.8) | 11.5 (2.8) | 11.4 (2.7) |
| Reduced motivation | 9.0 (3.8) | 10.6 (3.6) | 9.8 (3.7) |
| Mental fatigue | 10.4 (3.5) | 10.5 (2.5) | 10.5 (3.0) |
| Pain; median (Q1,Q3)d | 20.5 (6.0,4) | 28.0 (22.0,33.0) | 26.5 (12.0,37.5) |
| HR-QoL; M(SD)e | |||
| SF-36-PCS | 42.7 (7.6) | 37.1 (6.8) | 39.6 (7.5) |
| SF-36-MCS | 50.4 (7.6) | 54.4 (7.6) | 52.6 (7.7) |
| Self-efficacy; M(SD)f | 30.2 (3.5) | 29.2 (5.0) | 29.7 (4.2) |
| Lipids (mmol/l) | |||
| Cholesterol (total); M(SD) | 5.7 (1.2) | 5.2 (1.4) | 5.4 (1.3) |
| HDL; M(SD) | 1.5 (0.4) | 1.4 (0.4) | 1.5 (0.4) |
| LDL; M(SD) | 3.2 (1.1) | 3.0 (1.1) | 3.2 (1.1) |
| Triglyceride; median (Q1,Q3) | 1.7 (1.3,2.2) | 1.0 (0.9,1.8) | 1.4 (0.9,2.1) |
| HbA1c (mmol/mol)a; median (Q1,Q3) | 5.6 (5.4,5.8) | 5.6 (5.5,5.7) | 5.6 (5.4,5.8) |
| Blood pressure (mmHg); M(SD) | |||
| Systolic | 133.8 (18.0) | 122.0 (23.4) | 128.2 (21.0) |
| Diastolic | 81.0 (10.2) | 75.0 (10.8) | 78.1 (10.7) |
| Weight (kg); M(SD) | 84.3 (22.0) | 72.4 (10.8) | 78.7 (18.2) |
| Waist circumference (cm); M(SD) | 88.9 (24.5) | 84.4 (9.3) | 86.8 (18.6) |
| BMI; M(SD) | 28.7 (6.5) | 21.9 (4.2) | 25.5 (6.5) |
| Waist-hip-ratio; M(SD) | 0.9(0.2) | 0.9 (0.1) | 0.9 (0.1) |
aParticipants were not fasting before measurement of HbA1c
bHigher scores indicate higher degree of disability
cHigher scores indicate higher level of fatigue
dHigher scores indicate higher level of pain
eHigher scores indicate better HR-QoL
fHigher scores indicate higher level of self-efficacy